Clinical Trials Directory

Trials / Completed

CompletedNCT01145599

Identifying Progression of Retinal Disease in Eyes With NPDR in Diabetes Type 2 Using Non-invasive Procedures

Identifying Progression of Retinal Disease in Eyes With Non Proliferative Diabetic Retinopathy in Diabetes Type 2 Using Non-invasive Procedures

Status
Completed
Phase
Study type
Observational
Enrollment
374 (actual)
Sponsor
European Vision Institute Clinical Research Network · Network
Sex
All
Age
35 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify eyes that show worsening and disease progression (progressor phenotypes).

Detailed description

To identify "progressors" in retinal vascular disease and central retinal edema in type 2 diabetic patients with early NPDR, based on retinal disease progression from baseline to the 12-month visit, assessed by the following biomarkers: * Microaneurysms turnover (MA formation rate over or equal to 2, i.e. number of new MA from baseline to the 12-month visit) computed from color fundus photographs using the RetmarkerDR software; and * Retinal thickness increase in eyes with retinal thickening (Increase in retinal thickness above normal range) in the central subfield, the inner ring and/or the outer ring Constantly Present, Present or Absent (as measured by OCT and considering the macula thickness normative data.

Conditions

Timeline

Start date
2010-09-01
Primary completion
2013-10-01
First posted
2010-06-16
Last updated
2015-02-11

Locations

1 site across 1 country: Portugal

Source: ClinicalTrials.gov record NCT01145599. Inclusion in this directory is not an endorsement.